University of Plymouth Researchers Link Global Surge in Liver Disease to Microplastic and Nanoplastic Accumulation

University of Plymouth researchers investigate "plastic-induced liver injury," suggesting microplastics may trigger inflammation and accelerate liver disease.

By: AXL Media

Published: Apr 23, 2026, 6:48 AM EDT

Source: Information for this report was sourced from EurekAlert!

The Liver as a Gatekeeper in a Plastic-Laden World

The liver serves as the body’s primary biological firewall, responsible for detoxifying every substance humans ingest through food, water, and air. However, recent evidence indicates that microplastics and nanoplastics are increasingly present in human liver tissue, as well as in wild animal populations globally. Professor Shilpa Chokshi, Director of the Centre of Environmental Hepatology, suggests that these particles may act as transport vehicles for harmful substances, including microbial pathogens and carcinogenic additives. As liver disease now accounts for one in 25 deaths worldwide, researchers believe that environmental plastic exposure must be considered alongside traditional risk factors like obesity and alcohol use to explain the rapid pace of this health crisis.

Evidence of Plastic-Induced Liver Injury in Animal Models

Extensive reviews of existing literature reveal that exposure to tiny plastic particles can trigger cellular events that closely resemble advanced stages of human liver disease. In animal studies, microplastics have been shown to cause fibrogenesis, oxidative stress, and chronic inflammation. These findings raise significant concerns about why humans would be any less susceptible to such damage. By establishing the concept of "plastic-induced liver injury," the research team at the University of Plymouth aims to categorize how these synthetic materials disrupt organ function. The study highlights that the interaction between plastics and biological tissues is no longer a theoretical risk but a measurable pathological process.

Amplifying the Impact of Existing Metabolic Conditions

A primary concern for health experts is how plastic particles might accelerate the progression of established conditions, such as metabolic dysfunction-associated steatotic liver disease (MASLD). MASLD currently affects more than one in three people worldwide, and researchers suspect that microplastics may interact with existing disease processes to amplify harm. By embedding themselves in the liver, these particles could potentially hinder the organ’s ability to recover from fat-induced or alcohol-related damage. This synergy between environmental pollutants and lifestyle-driven diseases presents a complex challenge for modern hepatology, requiring a new framework for diagnosis and treatment.